Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurin Wagner

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Molecular Therapy. Nucleic Acids|March 16, 2026
mRNA-based CAR T cell engineering: Unmodified mRNA enables high CAR expression without innate immune activation in T cellsNourhan Kahwaji, Niklas Kotzian, Jasmin Melissa Prinz, et al.
BMJ (Clinical Research Ed.)|October 22, 2020
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trialAndy Roemhild, Natalie Maureen Otto, Guido Moll, et al.
Science Advances|September 4, 2024
Effector memory-type regulatory T cells display phenotypic and functional instabilityDésirée Jacqueline Wendering, Leila Amini, Stephan Schlickeiser, et al.
Molecular Therapy. Advances|May 18, 2026
Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulationGhazaleh Zarrinrad, Lisa-Marie Burkhardt, Claudia Beltran-Mestres, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Molecular Therapy. Nucleic Acids|March 16, 2026
mRNA-based CAR T cell engineering: Unmodified mRNA enables high CAR expression without innate immune activation in T cellsNourhan Kahwaji, Niklas Kotzian, Jasmin Melissa Prinz, et al.
BMJ (Clinical Research Ed.)|October 22, 2020
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trialAndy Roemhild, Natalie Maureen Otto, Guido Moll, et al.
Science Advances|September 4, 2024
Effector memory-type regulatory T cells display phenotypic and functional instabilityDésirée Jacqueline Wendering, Leila Amini, Stephan Schlickeiser, et al.
Molecular Therapy. Advances|May 18, 2026
Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulationGhazaleh Zarrinrad, Lisa-Marie Burkhardt, Claudia Beltran-Mestres, et al.
Pageof 2